Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study

Lipophilic statins are promising candidates for breast cancer treatment. However, anticancer therapy requires much higher doses of statins than can be delivered orally, and such high doses are known to exert more adverse effects. The main objective of our study was to design a targeted, therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Matusewicz, Lucyna, Podkalicka, Joanna, Sikorski, Aleksander F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266203/
https://www.ncbi.nlm.nih.gov/pubmed/30388834
http://dx.doi.org/10.3390/cancers10110418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266203/
https://www.ncbi.nlm.nih.gov/pubmed/30388834
http://dx.doi.org/10.3390/cancers10110418

Ejemplares similares